Study Reveals CBDA’s Potential Neuroprotective Effects and Brain Benefits
This CBDA neuroprotective effects study highlights promising evidence that CBDA, a cannabis compound, may reduce neuroinflammation and improve brain insulin signaling. These findings suggest potential benefits for neurological conditions, though further…
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
The new medical cannabis clinical education graduate certificate at UMSOP equips healthcare professionals with evidence-based knowledge to improve patient care. This program enhances understanding of cannabis therapy, enabling informed clinical…
Comparative efficacy of non-pharmacological interventions for individuals with cannabis use disorder
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Daily Cannabis News Brief for August 21, 2026
This daily cannabis news digest August 2026 highlights emerging clinical updates on CBDA's potential to reduce neuroinflammation and improve brain insulin signaling. These findings could impact neurological condition management. Stay informed with the…
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
Recent research highlights the cbda therapeutic potential neuroinflammation benefits, showing CBDA's ability to reduce brain inflammation and improve insulin signaling. These findings suggest promising applications for neurological and metabolic…
Navigating Federal Cannabis Home Cultivation Rights and Rescheduling
This article explores federal cannabis home cultivation rights amid rescheduling efforts, highlighting implications for medical research and patient care. Understanding these changes is vital for clinicians and patients navigating evolving cannabis…
DEA Has Published the Evidence Against Marijuana Rescheduling
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Comparing Non-Pharmacological Treatments for Cannabis Use Disorder
This article examines the efficacy of non-pharmacological interventions cannabis use disorder patients can benefit from. It highlights age-specific treatment responses and the importance of tailored approaches. Clinicians can use this evidence to improve…
Microbiota and the Endocannabinoid System
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
